Clinical Trials List
2024-09-01 - 2024-12-11
Phase I/II
Recruiting5
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 顏志傑 Division of Hematology & Oncology
- Yan-Shen Shan Division of General Surgery
- Chien-Jui Huang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chung-Pin Li Division of General Internal Medicine
- Shao-Jung Hsu Division of General Internal Medicine
- San-Chi Chen Division of Hematology & Oncology
- 黃宣恩 Division of Radiology
- Yi-Ping Hung Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Hung-Yuan Yu Division of General Internal Medicine
- 唐振育 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chi Chou Division of Hematology & Oncology
- 陳建銘 Division of Radiology
- Chun-Nan Yeh Division of General Surgery
- Hung-Chih Hsu Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- 蔡駿逸 Division of General Surgery
- Yung-Chia Kao Division of Hematology & Oncology
- Chan-Keng Yang Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Tai-Sen Yeh Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shau-Hsuan Li Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- 歐信佑 Division of Radiology
- 林昶廷 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- 王幸婷 Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
320 participants
